You may download the full texte or visit the the News Room of EDQM:https://www.edqm.eu/en/-/new-edqm-guidelines-on-medication-review-just-released  

Executive summary
Medication review (MR) is a structured and systematic evaluation of a patient’s medicines with the aim of optimising their use and improving health outcomes. It involves the identification of actual or potential medicine-related problems (MRPs) and results in recommendations to optimise medicine use.
Guideline scope and aims

This guidance is intended for competent national authorities and policy makers, pharmacists and healthcare professionals conducting MR and for health service organisations establishing MR programmes.
The primary aims of the guidance are:
• to establish a common understanding of what MR is and how it contributes to improving the use of medicines;
• to set out the process of conducting a MR (including the identification and prioritisation of patients who would benefit from a MR, and the recommended frequency of MRs);
• to provide some insights on how to support the development of this service and to facilitate the implementation into practice at European level.